| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Molecular Physiology and Biophysics [J. G.], Pathology [S. T., J. K.], and Medicine [J. K.], University of Vermont, Burlington, Vermont 05405
The INK4 family of proteins consists of four members which can block progression from the G1-to-S phase of the cell cycle by inhibiting the activity of cyclin dependent kinases (cdks) 4 and 6. Although the gene encoding p16INK4a is commonly inactivated in human tumors, p18INK4c is rarely altered. We show here that overexpression of p18INK4c does not block cell cycle progression in a T-cell acute lymphocytic leukemia cell line (CEM) sensitive to p16INK4a-mediated G1 arrest. A chimera consisting of the kinase-binding region of p16INK4a fused to the COOH terminus of p18INK4c is active in all known biochemical assays for INK4 function, but it does not arrest CEM cells. These data imply a novel level of p18INK4c regulation mediated through the COOH terminus and suggest that functional differences might underlie the distinct mutational profiles observed for p16INK4a and p18INK4c in tumors.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |